文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

视网膜色素上皮先天性肥大用于家族性腺瘤性息肉病的诊断——伊朗首个家族性腺瘤性息肉病登记处

Congenital Hypertrophy of Retinal Pigment Epithelium for Diagnosis of Familial Adenomatous Polyposis - the First FAP registry in Iran.

作者信息

Mirinezhad Seyed Kazem, Mousavi Farideh, Baghri Masood, Sepehri Bita, Ghavidel Ali, Ghojazadeh Morteza, Somi Mohammad Hossein

机构信息

Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Email:

出版信息

Asian Pac J Cancer Prev. 2018 Jan 27;19(1):167-169. doi: 10.22034/APJCP.2018.19.1.167.


DOI:10.22034/APJCP.2018.19.1.167
PMID:29373909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5844612/
Abstract

Objective: Familial adenomatous polyposis (FAP), an autosomal dominant inherited disorder is characterized by the presence of multiple adenomatous colorectal polyps, which can develop into cancer during early adulthood. Therefore, early diagnosis is essential. Most FAP patients have several extracolonic manifestations, including congenital hypertrophy of the retinal pigment epithelium (CHRPE). Whereas genetic markers may provide the main route to detection of ‘‘at risk’’ subjects , at present this approach is clearly limited and searches for a noninvasive phenotypic marker continue to be high priority.The aim of this study was to describe the pattern of distribution of CHRPE lesions and evaluate their diagnostic value in FAP patients and their family members in a local population. Methods: A total of 23 FAP patients and 26 relatives belonging to 12 families at high risk of developing FAP were subjected to colonoscopic and ophthalmological examination. Result: Retinal examinations demonstrated prevalences of CHRPE in FAP patents and their siblings of 78% and 38%, respectively. We were able to illustrate a significant correlation between FAP disease and the presence of retinal lesions. Sensitivity and specificity of CHRPE as a screening test to detect the presence of FAP are 78.3% and 61.5%, respectively, with a positive predictive value of 64.3% and a negative predictive value of 76.2 %. A “lesion form” significant difference was found between FAP and normal participants.Spearman nonparametric analysis revealed no correlation between age and number or size of lesions. Conclusion: Multiple CHRPE lesions are a diagnostic feature of FAP patients They are specific and sensitive clinical markers of this disease (specificity 60% and sensitivity 77%).

摘要

目的:家族性腺瘤性息肉病(FAP)是一种常染色体显性遗传性疾病,其特征是存在多个结直肠腺瘤性息肉,这些息肉在成年早期可能发展为癌症。因此,早期诊断至关重要。大多数FAP患者有几种结肠外表现,包括视网膜色素上皮先天性肥大(CHRPE)。虽然基因标记可能是检测“高危”人群的主要途径,但目前这种方法显然有限,寻找非侵入性表型标记仍然是当务之急。本研究的目的是描述CHRPE病变的分布模式,并评估其在当地人群中FAP患者及其家庭成员中的诊断价值。方法:对12个有FAP发病高风险家庭的23例FAP患者和26名亲属进行结肠镜检查和眼科检查。结果:视网膜检查显示,FAP患者及其兄弟姐妹中CHRPE的患病率分别为78%和38%。我们能够说明FAP疾病与视网膜病变的存在之间存在显著相关性。CHRPE作为检测FAP存在的筛查试验,其敏感性和特异性分别为78.3%和61.5%,阳性预测值为64.3%,阴性预测值为76.2%。在FAP患者和正常参与者之间发现了“病变形式”的显著差异。Spearman非参数分析显示年龄与病变数量或大小之间无相关性。结论:多个CHRPE病变是FAP患者的诊断特征。它们是这种疾病的特异性和敏感性临床标记(特异性60%,敏感性77%)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858a/5844612/49050e62092a/APJCP-19-167-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858a/5844612/9a13507f2e81/APJCP-19-167-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858a/5844612/49050e62092a/APJCP-19-167-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858a/5844612/9a13507f2e81/APJCP-19-167-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/858a/5844612/49050e62092a/APJCP-19-167-g002.jpg

相似文献

[1]
Congenital Hypertrophy of Retinal Pigment Epithelium for Diagnosis of Familial Adenomatous Polyposis - the First FAP registry in Iran.

Asian Pac J Cancer Prev. 2018-1-27

[2]
Congenital hypertrophy of retinal pigment epithelium (CHRPE) in patients with familial adenomatous polyposis (FAP); a polyposis registry experience.

BMC Res Notes. 2014-10-18

[3]
Congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis. Novel criteria of assessment and correlations with constitutional adenomatous polyposis coli gene mutations.

Cancer. 1996-12-1

[4]
Study of diagnostic value of congenital hypertrophy of retinal pigment epithelium in Chinese familial adenomatous polyposis patients.

Eur J Cancer Prev. 2022-9-1

[5]
Congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial colorectal cancer.

Fam Cancer. 2006

[6]
Incidence and predictive value of congenital hypertrophy of retinal pigment epithelium in Chinese familial adenomatous polyposis patients.

Chin Med J (Engl). 1998-3

[7]
Congenital hypertrophy of the retinal pigment epithelium (CHRPE) and familial adenomatous polyposis (FAP).

Acta Ophthalmol Scand. 1996-8

[8]
Ophthalmic and genetic screening in pedigrees with familial adenomatous polyposis.

Am J Ophthalmol. 1998-5

[9]
Congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis.

Ophthalmology. 1989-6

[10]
[Value of congenital hypertrophy of the retinal pigment epithelium as diagnostic marker in familial adenomatous polyposis].

Acta Med Port. 1993-7

引用本文的文献

[1]
Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision.

Br J Surg. 2024-5-3

[2]
Diagnostic implications of Gardner Syndrome, case report of a familial adenomatous polyposis (FAP) variant, for eye care professionals.

Int J Surg Case Rep. 2024-3

[3]
Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) as a Screening Marker for Familial Adenomatous Polyposis (FAP): Systematic Literature Review and Screening Recommendations.

Clin Ophthalmol. 2022-3-15

[4]
Recent advances in targeted therapy of colorectal cancer: impacts of monoclonal antibodies nanoconjugates.

Bioimpacts. 2019

本文引用的文献

[1]
Detecting APC Gene Mutations in Familial Adenomatous Polyposis (FAP).

Curr Protoc Hum Genet. 2017-1-11

[2]
Congenital hypertrophy of retinal pigment epithelium (CHRPE) in patients with familial adenomatous polyposis (FAP); a polyposis registry experience.

BMC Res Notes. 2014-10-18

[3]
Diagnosis, surveillance, and treatment strategies for familial adenomatous polyposis: rationale and update.

Eur J Gastroenterol Hepatol. 2014-3

[4]
Congenital hypertrophy of the retinal pigment epithelium complicated by a choroidal neovascular membrane.

Digit J Ophthalmol. 2013-5-1

[5]
FAP, gastric cancer, and genetic counseling featuring children and young adults: a family study and review.

Fam Cancer. 2010-12

[6]
Extra-intestinal manifestations of familial adenomatous polyposis.

Ann Surg Oncol. 2008-9

[7]
Congenital hypertrophy of the retinal pigment epithelium: prevalence and ocular features in the optometric population.

Ophthalmic Physiol Opt. 2007-11

[8]
Congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial colorectal cancer.

Fam Cancer. 2006

[9]
Value of the congenital hypertrophy of the retinal pigment epithelium in the diagnosis of familial adenomatous polyposis.

Int Ophthalmol. 2004-3

[10]
Familial adenomatous polyposis.

Gastrointest Endosc. 2003-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索